Aredia Patients Push For Dental Monitoring Class

Law360, New York (August 28, 2007, 12:00 AM EDT) -- Seeking to open another front in the war against Novartis Pharmaceuticals Corp., a second group of plaintiffs has asked to be certified as a class in the Aredia and Zometa product liability litigation. These plaintiffs, who might be at risk, want to be monitored for the jaw deterioration the drugs allegedly cause.

On Monday, class representatives Sybila Dean and Duncan Lee filed their certification motion in the U.S. District Court for the Middle District of Tennessee, urging the court to allow Aredia and Zometa patients to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.